About VPD-HLRI
The Victor Phillip Dahdaleh Heart and Lung Research Institute (VPD-HLRI) is a joint venture between Royal Papworth Hospital and the University of Cambridge.
Based on the Cambridge Biomedical Campus, the VPD-HLRI combines world-leading life science, translational research and clinical excellence.
By bringing together the NHS, academia, industry and charity, it has created a unique environment to deliver high-impact research tackling global cardiovascular and respiratory diseases - some of the world's biggest killers.
VPD-HLRI is next to our hospital on the Cambridge Biomedical Campus, the largest biotech cluster outside the United States.
The near-400 researchers, scientists and clinicians based inside HLRI are united in their focus on prevention, early diagnosis and treatment of heart and lung diseases. They are creating, testing and delivering new treatments to tackle the biggest causes of premature death in the world all on one site.
Royal Papworth Charity contributed £5 million to support the build to ensure our patients have access to the world’s best treatment.
Unmet needDespite a growing awareness of risk factors, cardiovascular and lung disease is increasing. There are 27 million deaths caused by cardiovascular and lung diseases each year. |
Other funders include:
The UK Research Partnership Investment Fund
The University of Cambridge
VPD-HLRI in pictures
From construction starting in 2020 to the official opening by HRH Duchess of Gloucester in 2022, explore the VPD-HLRI in pictures.
